Metrics
3 File views/ downloads
21 Record Views
Presentation
Semaglutide vs. Traditional Therapy for Weight Loss in Type II Diabetes
University of West Florida Libraries
Integration of Evidence in Professional Nursing Practice Research Presentations, Research presentations (University of West Florida, Pensacola, Florida, 08/2025)
08/2025
Abstract
Obesity and type II diabetes presents a significant problem in the United States. Weight loss and management can be a challenge. Overweight increases risks of comorbidities. Type II diabetics are more susceptible to weight gain. Overweight increases hunger due to increased adiposity and hormonal signaling. Semaglutide is a GLP 1 antagonist that decreases hunger and impacts insulin regulation.
Details
- Title
- Semaglutide vs. Traditional Therapy for Weight Loss in Type II Diabetes
- Resource Type
- Presentation
- Event
- Integration of Evidence in Professional Nursing Practice Research Presentations, Research presentations (University of West Florida, Pensacola, Florida, 08/2025)
- Contributors
- Brenda Mutchler (Faculty Mentor)
- Publisher
- University of West Florida Libraries; Argo Scholar Commons
- Format
- mp4
- Copyright
- Permission granted to the University of West Florida Libraries by the author to digitize and/or display this information for non-profit research and educational purposes. Any reuse of this item in excess of fair use or other copyright exemptions requires the permission of the copyright holder.
- Identifiers
- 99381460524806600
- Academic Unit
- School of Nursing; Usha Kundu, MD College of Health; BSN Virtual Student Scholarly Poster Showcase
- Language
- English